Topics
October 2020 | Meeting Minute
Subretinal Gene Therapy
This new technology is filled with promise.
Christina Y. Weng, MD, MBA, and Jonathan F. Russell, MD, PhD
Intraocular Tumors: A Look Into the Future
The Taylor Smith and Victor Curtin Lecture was given by Carol L. Shields, MD, at this year’s meeting.
Carol L. Shields, MD, and Jonathan F. Russell, MD, PhD
Aspen Retinal Detachment Society Meeting Coverage: Ocular Oncology and Retinal Gene Therapy
Timothy G. Murray, MD, MBA
June 8, 2026
Alkeus Doses First Patient in Global Phase 3 NORTHSTAR Trial of Gildeuretinol for Stargardt Disease
FDA Issues Draft Guidance to Accelerate Development of Gene Therapies Using Existing Scientific Knowledge
June 5, 2026
Large International Study Finds No Link Between Semaglutide and Wet AMD Risk
June 4, 2026
NEI-Supported Researchers Launch Open-Access Tool to Expand Access to Amblyopia Care for Children
May/June 2026 Insert
Editorially Independent Content, Supported With Advertising From Astellas
Editorially independent supported by Abbvie and Regenxbio
May/June 2026 Supplement
Free Print Subscription
Email Newsletter
Conference Calendar